Translating Real-World Data into Real-World Benefit

With the increasing availability and acceptance of real-world evidence outside of academic and institutional settings, community oncology practices are becoming significant and important consumers of this information. Real-world evidence is changing the way regulatory and clinical decisions are evaluated and made, including:

  • Demonstration of a therapy’s effectiveness
  • Label expansions
  • Patient outcomes
  • Support for clinical trial results
  • Changes to product administration protocols
Front & Center
Click here to download
Presented by
Pharmaceutical Executive
Sponsored by
McKesson